These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18380629)

  • 21. Rapid health technology assessment of the novel endonuclease inhibitor baloxavir for the treatment of influenza.
    Huang G; Tian Y; Cui W; Zhang X; Zhao Y; Liu X
    J Chemother; 2024 Jul; 36(4):267-282. PubMed ID: 37767970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
    Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
    Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analyses of natalizumab (Tysabri) compared with other disease-modifying therapies for people with highly active relapsing-remitting multiple sclerosis in the UK.
    Gani R; Giovannoni G; Bates D; Kemball B; Hughes S; Kerrigan J
    Pharmacoeconomics; 2008; 26(7):617-27. PubMed ID: 18563952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong Kong.
    You JH; Chan ES; Leung MY; Ip M; Lee NL
    PLoS One; 2012; 7(3):e33123. PubMed ID: 22479363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation.
    Murray A; Lourenco T; de Verteuil R; Hernandez R; Fraser C; McKinley A; Krukowski Z; Vale L; Grant A
    Health Technol Assess; 2006 Nov; 10(45):1-141, iii-iv. PubMed ID: 17083853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
    Tappenden P; Jones R; Paisley S; Carroll C
    Health Technol Assess; 2007 Mar; 11(12):1-128, iii-iv. PubMed ID: 17346499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis.
    Goodacre S; Sampson F; Stevenson M; Wailoo A; Sutton A; Thomas S; Locker T; Ryan A
    Health Technol Assess; 2006 May; 10(15):1-168, iii-iv. PubMed ID: 16707072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of screening for oral cancer in primary care.
    Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
    Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC
    Li X; Bilcke J; van der Velden AW; Bruyndonckx R; Coenen S; Bongard E; de Paor M; Chlabicz S; Godycki-Cwirko M; Francis N; Aabenhus R; Bucher HC; Colliers A; De Sutter A; Garcia-Sangenis A; Glinz D; Harbin NJ; Kosiek K; Lindbæk M; Lionis C; Llor C; Mikó-Pauer R; Radzeviciene Jurgute R; Seifert B; Sundvall PD; Touboul Lundgren P; Tsakountakis N; Verheij TJ; Goossens H; Butler CC; Beutels P;
    Eur J Health Econ; 2023 Aug; 24(6):909-922. PubMed ID: 36131214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic model for emergency use authorization of intravenous peramivir.
    Lee BY; Tai JH; Bailey RR; McGlone SM; Wiringa AE; Zimmer SM; Smith KJ; Zimmerman RK
    Am J Manag Care; 2011 Jan; 17(1):e1-9. PubMed ID: 21485418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States.
    Talbird SE; Brogan AJ; Winiarski AP; Sander B
    Am J Health Syst Pharm; 2009 Mar; 66(5):469-80. PubMed ID: 19233995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and cost-effectiveness of the Ross procedure versus conventional aortic valve replacement in young adults.
    Thom H; Visan AC; Keeney E; Dorobantu DM; Fudulu D; T A Sharabiani M; Round J; Stoica SC
    Open Heart; 2019; 6(1):e001047. PubMed ID: 31275578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuraminidase inhibitors for preventing and treating influenza in children.
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults.
    Lee PY; Matchar DB; Clements DA; Huber J; Hamilton JD; Peterson ED
    Ann Intern Med; 2002 Aug; 137(4):225-31. PubMed ID: 12186512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K.
    Meier G; Gregg M; Poulsen Nautrup B
    J Med Econ; 2015; 18(9):746-61. PubMed ID: 25903831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom.
    Veenstra DL; Sullivan SD; Dusheiko GM; Jacobs M; Aledort JE; Lewis G; Patel KK
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):631-8. PubMed ID: 17625431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.